scholarly article | Q13442814 |
P50 | author | Emily Chew | Q24266614 |
Amitha Domalpally | Q42716579 | ||
P2093 | author name string | R P Danis | |
B A Blodi | |||
Age-Related Eye Disease Study 2 (AREDS2) Research Group | |||
R Trane | |||
T E Clemons | |||
P2860 | cites work | Ranibizumab and bevacizumab for neovascular age-related macular degeneration | Q24616209 |
Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects | Q26774188 | ||
Five-Year Outcomes with Anti-Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials | Q28049700 | ||
Ranibizumab for neovascular age-related macular degeneration | Q29617549 | ||
The prevalence of age-related macular degeneration and associated risk factors | Q33957918 | ||
Blue-light versus green-light autofluorescence: lesion size of areas of geographic atrophy. | Q34081266 | ||
Ranibizumab versus verteporfin for neovascular age-related macular degeneration. | Q34652928 | ||
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17 | Q34653094 | ||
Growth of geographic atrophy in the comparison of age-related macular degeneration treatments trials | Q35214092 | ||
Progression of retinal pigment epithelial atrophy in antiangiogenic therapy of neovascular age-related macular degeneration. | Q35601906 | ||
Association of Baseline Characteristics and Early Vision Response with 2-Year Vision Outcomes in the Comparison of AMD Treatments Trials (CATT) | Q35780510 | ||
Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials | Q35897354 | ||
Predictors of Macular Atrophy Detected by Fundus Autofluorescence in Patients With Neovascular Age-Related Macular Degeneration After Long-Term Ranibizumab Treatment | Q35960504 | ||
PROGRESSION OF MACULAR ATROPHY IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION UNDERGOING ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. | Q36004881 | ||
Incidence and Growth of Geographic Atrophy during 5 Years of Comparison of Age-Related Macular Degeneration Treatments Trials | Q36247080 | ||
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1) | Q36360812 | ||
Methods and reproducibility of grading optimized digital color fundus photographs in the Age-Related Eye Disease Study 2 (AREDS2 Report Number 2) | Q36996217 | ||
Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials | Q39830867 | ||
Drusen Volume as a Predictor of Disease Progression in Patients With Late Age-Related Macular Degeneration in the Fellow Eye. | Q39848356 | ||
Macular Atrophy in Neovascular Age-Related Macular Degeneration with Monthly versus Treat-and-Extend Ranibizumab: Findings from the TREX-AMD Trial. | Q40467797 | ||
The Wisconsin age-related maculopathy grading system | Q41902806 | ||
Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11. | Q42716529 | ||
Macular atrophy progression and 7-year vision outcomes in subjects from the ANCHOR, MARINA, and HORIZON studies: the SEVEN-UP study | Q46247369 | ||
Causes and prevalence of visual impairment among adults in the United States | Q46890945 | ||
MACULAR ATROPHY FINDINGS BY OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY COMPARED WITH FUNDUS AUTOFLUORESCENCE IN TREATED EXUDATIVE AGE-RELATED MACULAR DEGENERATION. | Q49488840 | ||
Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. | Q52886344 | ||
OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF THE FOVEAL MICROVASCULATURE IN GEOGRAPHIC ATROPHY. | Q53047129 | ||
Evolution of Geographic Atrophy in Participants Treated with Ranibizumab for Neovascular Age-related Macular Degeneration | Q88345802 | ||
P433 | issue | 10 | |
P921 | main subject | eye disease | Q3041498 |
macular degeneration | Q27429789 | ||
P304 | page(s) | 1021-1027 | |
P577 | publication date | 2018-06-02 | |
P1433 | published in | Ophthalmology Retina | Q63241478 |
P1476 | title | Atrophy in Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 15 | |
P478 | volume | 2 |
Q92456774 | A Review of Macular Atrophy of the Retinal Pigment Epithelium in Patients with Neovascular Age-Related Macular Degeneration: What is the Link? Part II | cites work | P2860 |
Search more.